If prophylactic HPV vaccination is considered in a woman with CIN2+, what is the value and should it be given before or after the surgical treatment?
Wiebren Tjalma, Jaques van Heerden, Tim Van den Wyngaert
Topics & Concepts
MedicineVaccinationCervical cancerClinical trialRandomized controlled trialGynecologyPediatricsCancerSurgeryInternal medicineImmunologyCervical Cancer and HPV ResearchReproductive tract infections researchDiphtheria, Corynebacterium, and Tetanus